Abbvie said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...
2don MSN
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...
The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback